Inspire Medical Systems, Inc. Tax Withholding Paid on Stock Awards
Inspire Medical Systems, Inc. (INSP) reported Tax Withholding Paid on Stock Awards of $8.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-03
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $685.00K, a 60.45% decline year-over-year.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $7.59M, a 60.45% decline year-over-year.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $694.00K.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $1.43M, a 67.10% decline year-over-year.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $23.04M, a 346.16% increase from fiscal 2024.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $5.17M, a 69.90% decline from fiscal 2023.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $17.16M, a 39802.33% increase from fiscal 2022.
- Inspire Medical Systems, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $43.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $685.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $8.28M 10-Q · filed 2026-08-03 | $8.97M derived: sum of 3 quarters · filed 2026-08-03 | $10.40M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $7.59M 10-Q · filed 2026-05-04 | $8.29M derived: sum of 2 quarters · filed 2026-05-04 | $9.71M derived: sum of 3 quarters · filed 2026-05-04 | $11.44M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.12M derived: sum of 2 quarters · filed 2026-02-13 | $3.85M derived: sum of 3 quarters · filed 2026-08-03 | $23.04M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $3.16M derived: sum of 2 quarters · filed 2026-08-03 | $22.35M 10-Q · filed 2025-11-03 | $18.47M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $20.92M 10-Q · filed 2026-08-03 | $17.04M derived: sum of 3 quarters · filed 2026-08-03 | $21.38M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $19.19M 10-Q · filed 2026-05-04 | $15.31M derived: sum of 2 quarters · filed 2026-05-04 | $19.65M derived: sum of 3 quarters · filed 2026-05-04 | $21.51M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $455.00K derived: sum of 2 quarters · filed 2026-02-13 | $2.32M derived: sum of 3 quarters · filed 2026-02-13 | $5.17M 10-K · filed 2026-02-13 |
| 2024-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $6.20M derived: sum of 2 quarters · filed 2025-11-03 | $9.04M 10-Q · filed 2025-11-03 | $22.97M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $4.71M 10-Q · filed 2025-08-04 | $18.64M derived: sum of 3 quarters · filed 2026-02-13 | $19.15M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $2.85M 10-Q · filed 2025-05-05 | $16.77M derived: sum of 2 quarters · filed 2026-02-13 | $17.29M derived: sum of 3 quarters · filed 2026-02-13 | $18.26M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $13.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $14.44M derived: sum of 2 quarters · filed 2026-02-13 | $15.41M derived: sum of 3 quarters · filed 2026-02-13 | $17.16M 10-K · filed 2026-02-13 |
| 2023-09-30 | $516.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $1.49M derived: sum of 2 quarters · filed 2024-11-04 | $3.23M 10-Q · filed 2024-11-04 | $3.23M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $971.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.72M 10-Q · filed 2024-08-06 | $2.72M derived: sum of 3 quarters · filed 2025-02-10 | $2.72M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $1.75M 10-Q · filed 2024-05-07 | $1.75M derived: sum of 2 quarters · filed 2025-02-10 | $1.75M derived: sum of 3 quarters · filed 2025-02-10 | $1.75M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $0.00 derived: sum of 2 quarters · filed 2025-02-10 | $0.00 derived: sum of 3 quarters · filed 2025-02-10 | $43.00K 10-K · filed 2025-02-10 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $43.00K 10-Q · filed 2023-11-07 | $43.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $43.00K 10-Q · filed 2023-08-01 | $43.00K derived: sum of 3 quarters · filed 2024-02-09 | $43.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $43.00K 10-Q · filed 2023-05-02 | $43.00K derived: sum of 2 quarters · filed 2024-02-09 | $43.00K derived: sum of 3 quarters · filed 2024-02-09 | $43.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-09 | $0.00 10-K · filed 2024-02-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |